Summary
Announces availability of draft guidance on Predetermined Change Control Plans for medical devices, describing how sponsors can pre‑specify certain post‑market modifications and validation methods.
Healthcare Implications
Facilitates responsible iteration of AI‑enabled devices via pre‑authorized change plans, enabling faster updates with appropriate safeguards.